Analyzing OneMedNet (ONMD) and Its Competitors

OneMedNet (NASDAQ:ONMD) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it compare to its rivals? We will compare OneMedNet to similar companies based on the strength of its institutional ownership, profitability, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.9% of OneMedNet shares are held by institutional investors. Comparatively, 42.3% of shares of all “Healthcare Technology” companies are held by institutional investors. 50.2% of OneMedNet shares are held by company insiders. Comparatively, 16.0% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares OneMedNet and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
OneMedNet	$1.36 million	-$2.80 million	-2.64
OneMedNet Competitors	$342.33 million	-$24.15 million	12.93

OneMedNet’s rivals have higher revenue, but lower earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings for OneMedNet and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	1	0	0	0	1.00
OneMedNet Competitors	446	1517	2724	88	2.51

As a group, “Healthcare Technology” companies have a potential upside of 40.15%. Given OneMedNet’s rivals stronger consensus rating and higher probable upside, analysts plainly believe OneMedNet has less favorable growth aspects than its rivals.

Profitability

This table compares OneMedNet and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OneMedNet	-584.20%	N/A	-521.20%
OneMedNet Competitors	-778.92%	-33.96%	-15.64%

Risk and Volatility

OneMedNet has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, OneMedNet’s rivals have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.

Summary

OneMedNet rivals beat OneMedNet on 8 of the 13 factors compared.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.